Advanced HIV rapid ART — DTM&H MCQ

Correct answer: D — Start cotrimoxazole and rapid antiretroviral therapy after same-day readiness assessment

The correct answer is D, start cotrimoxazole and rapid antiretroviral therapy after same-day readiness assessment. This man has clinical features of advanced HIV disease (oral candidiasis, weight loss) with a negative TB screen and no signs of meningitis, so there is no clinical contraindication to immediate treatment. WHO guidance for advanced HIV disease states that the inability to perform baseline tests, or delay in results, should not delay ART initiation except where there is clinical suspicion of TB or cryptococcal meningitis, in which case ART is deferred pending investigation. Cotrimoxazole prophylaxis, and ART, should be started together on the same day once major opportunistic CNS infections are excluded, particularly when loss to follow-up is likely, as here given his rural residence and distance from care. Why the other options are wrong: B. Delay ART for 1 month to repeat CD4 count: waiting for repeat CD4 delays treatment of a patient with advanced disease and high risk of pre-treatment loss to follow-up and mortality, with no clinical justification for the delay. C. Give fluconazole and wait for viral load: oral thrush needs only clinical assessment, not fluconazole pre-emptive therapy for systemic disease, and viral load monitoring is used after ART initiation, not as a prerequisite to starting treatment. A. Refer to a distant clinic before any treatment: he may not return if referred elsewhere first, so this risks total loss to follow-up and preventable death rather than protecting him. E. Start TB treatment without screening results: his TB screen was negative, so empirical TB treatment is unjustified and exposes him to unnecessary drug toxicity without evidence of active disease. Key point: In advanced HIV disease without meningitis or active TB, cotrimoxazole and ART should be started the same day after a rapid readiness check, since delay for tests he may never return for causes more harm than any theoretical benefit of waiting.

Reference: World Health Organization, Guidelines for Managing Advanced HIV Disease and Rapid Initiation of Antiretroviral Therapy, Geneva 2017 (https://www.ncbi.nlm.nih.gov/books/NBK475972/)